Tectonic Shareholders Equity Per Share from 2010 to 2025

TECX Stock   40.16  3.71  8.46%   
Tectonic Therapeutic, Shareholders Equity Per Share yearly trend continues to be fairly stable with very little volatility. Shareholders Equity Per Share is likely to outpace its year average in 2025. During the period from 2010 to 2025, Tectonic Therapeutic, Shareholders Equity Per Share regression line of annual values had r-squared of  0.21 and arithmetic mean of  27.88. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
23.08
Current Value
37.25
Quarterly Volatility
35.11225936
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tectonic Therapeutic, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tectonic Therapeutic,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Other Operating Expenses of 77.8 M or Research Development of 54.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.7. Tectonic financial statements analysis is a perfect complement when working with Tectonic Therapeutic, Valuation or Volatility modules.
  
Check out the analysis of Tectonic Therapeutic, Correlation against competitors.
For more information on how to buy Tectonic Stock please use our How to Invest in Tectonic Therapeutic, guide.

Latest Tectonic Therapeutic,'s Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of Tectonic Therapeutic, over the last few years. It is Tectonic Therapeutic,'s Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tectonic Therapeutic,'s overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Slightly volatile
   Shareholders Equity Per Share   
       Timeline  

Tectonic Shareholders Equity Per Share Regression Statistics

Arithmetic Mean27.88
Geometric Mean9.79
Coefficient Of Variation125.93
Mean Deviation27.51
Median20.68
Standard Deviation35.11
Sample Variance1,233
Range107
R-Value0.46
Mean Square Error1,045
R-Squared0.21
Significance0.08
Slope3.37
Total Sum of Squares18,493

Tectonic Shareholders Equity Per Share History

2025 37.25
2024 23.08
2023 25.65
2022 20.68
2021 47.46
2020 84.3
2019 81.37

About Tectonic Therapeutic, Financial Statements

Tectonic Therapeutic, investors use historical fundamental indicators, such as Tectonic Therapeutic,'s Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tectonic Therapeutic,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 23.08  37.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tectonic Stock Analysis

When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.